Latest Administration News

Alterity Therapeutics has secured FDA Fast Track designation for ATH434, its lead candidate for treating Multiple System Atrophy, potentially speeding up regulatory review and bringing hope to patients with this rare neurodegenerative disorder.

Westpac Banking Corporation has announced a fully franked interim dividend of AUD 0.76 per share for the half-year ending March 2025, payable in June with a Dividend Reinvestment Plan available to eligible shareholders.

Classic Minerals Limited has completed the sale of its Kat Gap tenements for A$7 million, using the proceeds to retire debt and accelerate exploration at its Lady Ada and Lady Magdalene gold projects within the Forrestania region.

Yowie Group Ltd has responded to ASX queries detailing a significant revenue impact from reduced store facings and clarified complex loan arrangements with Keybridge Capital Limited amid ongoing solvency concerns.

Ecofibre Limited’s shares have been suspended from trading following the appointment of voluntary administrators, reflecting severe financial distress and regulatory concerns.

High-Tech Metals Limited has raised $1.26 million through a share placement backed by a cornerstone investment from Ragnar Metals, which now gains board representation. This capital injection aims to accelerate exploration activities across HTM’s project portfolio.

Anagenics Limited has completed a significant restructuring to simplify operations and issued 35 million shares to FOS Capital as part of this process. The company confirms its going concern status and outlines plans for organic and acquisitive growth over the next year.

Yowie Group has clarified misleading substantial shareholder notices linked to Keybridge Capital's administration, denying any current plans for board changes and highlighting ongoing legal disputes.

Cazaly Resources has issued a replacement Appendix 5B for the March 2025 quarter to correct an administrative error, reaffirming a solid cash position with over six quarters of funding available.

Oncosil Medical Ltd has announced a significant 400-for-1 security consolidation affecting shares, options, and performance rights, with shareholder approval scheduled for late May 2025.

Southern Cross Gold Consolidated Ltd has successfully arranged an upsized C$143 million funding round to fast-track its Sunday Creek Gold-Antimony Project in Victoria, Australia. This capital injection positions the company to advance drilling, underground development, and economic assessments over the coming years.

VanEck Investments Limited has released a replacement Product Disclosure Statement for six Australian bond ETFs, reflecting updated reference indices and market conditions effective May 1, 2025.